4.8 Article

Structural basis for selective binding of m6A RNA by the YTHDC1 YTH domain

期刊

NATURE CHEMICAL BIOLOGY
卷 10, 期 11, 页码 927-929

出版社

NATURE PUBLISHING GROUP
DOI: 10.1038/NCHEMBIO.1654

关键词

-

资金

  1. AbbVie
  2. Boehringer Ingelheim
  3. Canada Foundation for Innovation
  4. Canadian Institutes for Health Research
  5. Genome Canada through the Ontario Genomics Institute [OGI-055]
  6. GlaxoSmithKline
  7. Janssen
  8. Lilly Canada
  9. Novartis Research Foundation
  10. Ontario Ministry of Economic Development and Innovation
  11. Pfizer
  12. Takeda
  13. Wellcome Trust [092809/Z/10/Z]
  14. Howard Hughes Medical Institute
  15. National Science Foundation [CHE-1048528]

向作者/读者索取更多资源

N-6-methyladenosine (m(6)A) is the most abundant internal modification of nearly all eukaryotic mRNAs and has recently been reported to be recognized by the YTH domain family proteins. Here we present the crystal structures of the YTH domain of YTHDC1, a member of the YTH domain family, and its complex with an m(6)A-containing RNA. Our structural studies, together with transcriptome-wide identification of YTHDC1-binding sites and biochemical experiments, not only reveal the specific mode of m(6)A-YTH binding but also explain the preferential recognition of the GG(m(6)A)C sequences by YTHDC1.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据